Related Experiment Videos
[Idiopathic hypertrophic cranial pachymeningitis]
1Neurologische Universitätsklinik Tübingen, Zentrum für Neurologie, Abteilung Allergie--Neurologie. dagmar.beier@medbo.de
Klinische Monatsblatter Fur Augenheilkunde
|September 22, 2005
Summary
Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare dural thickening disease. Early diagnosis and corticosteroid therapy can manage symptoms like headache and cranial nerve palsies.
Area of Science:
- Neurology
- Inflammatory Diseases
- Neuroimaging
Background:
- Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare, chronic inflammatory condition of unknown origin.
- Characterized by dural thickening and lymphocytic infiltrate, IHCP often presents with diverse neurological and ophthalmological symptoms.
- Delayed diagnosis is common due to symptom variability and association with other disorders.
Observation:
- A 51-year-old woman presented with visual disturbances, multiple cranial nerve palsies, headache, and unilateral body numbness.
- Brain MRI revealed focal dural thickening and associated bone thickening.
- Cerebrospinal fluid analysis showed lymphocytic pleocytosis, with elevated inflammatory markers (WBC, CRP, ESR).
Findings:
- Corticosteroid therapy led to initial remission, but the patient experienced relapses requiring dose adjustments.
- Long-term oral steroid treatment slowed disease progression and improved visual acuity.
- This case highlights bone involvement as a potential feature of IHCP.
Implications:
- Chronic headache, ataxia, and cranial nerve palsies with dural thickening suggest IHCP.
- Ophthalmological and neurological symptoms can be associated with IHCP, necessitating thorough evaluation.
- Prompt diagnosis and management are crucial for mitigating disease progression and preserving neurological function.